DekaBank Deutsche Girozentrale
INFI

DekaBank Deutsche Girozentrale’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-21,500
Closed -$111K – 1058
2016
Q1 		$111K Sell
21,500
-3,300
-13% -$20.2K ﹤0.01% 942
2015
Q4 		$195K Hold
24,800
– – ﹤0.01% 870
2015
Q3 		$210K Buy
24,800
+1,000
+4% +$9.22K ﹤0.01% 858
2015
Q2 		$261K Buy
23,800
+900
+4% +$11.6K ﹤0.01% 824
2015
Q1 		$320K Sell
22,900
-3,100
-12% -$47.4K ﹤0.01% 814
2014
Q4 		$432K Sell
26,000
-2,400
-8% -$34.9K 0.01% 719
2014
Q3 		$381K Buy
28,400
+800
+3% +$9.53K 0.01% 713
2014
Q2 		$352K Sell
27,600
-1,000
-3% -$10.4K 0.01% 676
2014
Q1 		$340K Buy
28,600
+1,500
+6% +$20.1K 0.01% 645
2013
Q4 		$365K Buy
27,100
+400
+1% +$5.65K 0.01% 592
2013
Q3 		$466K Buy
26,700
+2,000
+8% +$38.3K 0.01% 556
2013
Q2 		$414K Buy
+24,700
New +$764K 0.01% 468

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DekaBank Deutsche Girozentrale's INFI Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 21,500 shares — an estimated $111K sold.

DekaBank Deutsche Girozentrale first reported a position in INFI in Q2 2013 and held it in 12 quarters. The position peaked at $466K in Q3 2013. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 21,500 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $111K.
  • DekaBank Deutsche Girozentrale first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 12 quarters.
  • DekaBank Deutsche Girozentrale's Infinity Pharmaceuticals, Inc. position peaked at $466K in Q3 2013.
  • 107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.